Back
Keros Therapeutics Vs. Lemonade Industry Stock Comparison
Buy
70
KROS
Keros Therapeutics
Last Price:
63.02
Seasonality Move:
23.73%
Buy
91
LMND
Lemonade
Last Price:
32.01
Seasonality Move:
29.67%
Buy
70
Keros Therapeutics (KROS)
is a Buy
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $64.80. The Score for KROS is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- KROS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
91
Lemonade (LMND)
is a Buy
Is Lemonade a Buy, Sell or Hold?
- The current Lemonade [LMND] share price is $32.27. The Score for LMND is 91, which is 82% above its historic median score of 50, and infers lower risk than normal.
- LMND is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $64.80
The current trend is moderately bullish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.3 | Buy |
| Relative Strength Index (14 RSI): | 59.62 | Buy |
| Chaikin Money Flow: | -438607 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.25 - 64.39) | Buy |
| Bollinger Bands (100): | (45.79 - 59.63) | Buy |
LMND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.5 | Buy |
| Relative Strength Index (14 RSI): | 74.87 | Buy |
| Chaikin Money Flow: | -2225126 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.38 - 26.6) | Buy |
| Bollinger Bands (100): | (15.39 - 22.43) | Buy |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.63 | Buy |
| 20-day SMA: | 61.86 | Buy |
| 50-day SMA: | 58.72 | Buy |
| 200-day SMA: | 55.34 | Buy |
| 8-day EMA: | 64.91 | Sell |
| 20-day EMA: | 62.49 | Buy |
| 50-day EMA: | 58.8 | Buy |
| 200-day EMA: | 52.93 | Buy |
LMND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.04 | Buy |
| 20-day SMA: | 22.66 | Buy |
| 50-day SMA: | 19.53 | Buy |
| 200-day SMA: | 17.84 | Buy |
| 8-day EMA: | 28.45 | Buy |
| 20-day EMA: | 24.22 | Buy |
| 50-day EMA: | 20.89 | Buy |
| 200-day EMA: | 18.31 | Buy |
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.51 per share.
Lemonade Earnings Growth & LMND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and an increase next year of $0.41 per share.
Keros Therapeutics Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lemonade Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||